2023 annual financial data
Aligos Therapeutics 2023 Net margin
Aligos Therapeutics 2023 net margin with verified reported values.
Direct answer
Net margin was -564.61%.
Operating income was -88,127,000 USD and net income was -87,679,000 USD.
Operating cash flow was -78,997,000 USD.
Get free Aligos Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 15,529,000 USD
- Operating income
- -88,127,000 USD
- Net income
- -87,679,000 USD
- Operating cash flow
- -78,997,000 USD